300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Beauty
Medical
Web3
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Fashion
Infrastructure
Social
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Burkina Faso
Africa
LATAM
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Paraguay
South Africa
Botswana
France
Denmark
Georgia
Ghana
Iraq
Sierra Leone
Philippines
El Salvador
Portugal
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Ecuador
Azerbaijan
Bahamas
Bahrain
Jersey
Estonia
Bulgaria
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Lebanon
Liechtenstein
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Olav Bergheim, Founder & MD at Fjord Ventures

Olav Bergheim

Founder & MD @ Fjord Ventures

Laguna Hills, United States

Olav Bergheim is a seed investor at Fjord Ventures in Laguna Hills focused on Medical and Wellness. Olav Bergheim has over 30 years of experience in creating and managing life science companies. He is a founder of Sonendo, Inc., in addition to several other successful life science companies including Volcano Corporation, 3F Therapeutics (acquired by Medtronic), Glaukos Corporation, Lonestar Heart Inc., Prelude Corporation and Metronom Health,Inc. Mr. Bergheim is also the founder of Fjord Ventures LLC, a life science accelerator located in Laguna Hills, California, where Sonendo was created. Mr. Bergheim was the chairman of Vessix Vascular, Inc. (acquired by Boston Scientific). Prior to starting Fjord Ventures, he spent 10 years at Domain Associates as a company creator and general partner. Prior to Domain, Mr. Bergheim spent 18 years with Baxter Healthcare at US and international locations, where he held various leadership and operating roles. Mr. Bergheim was a Corporate VP of Baxter as well as President of Baxter Germany, President of Baxter’s Cardiovascular Group (now Edwards Life Sciences) and General Manager of the Nordic area.

Total investments:
3
Last investment:
Lead investor:
0%

Last updated:

Industries Olav Bergheim invests in

MedicalWellnessHealth CareManufacturingIndustrial Automation

Stages Olav Bergheim invests in

SeedSeries DSeries E

Countries Olav Bergheim invests in

NorwayUnited States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 1 (33%)
  • Wellness 1 (33%)
  • Health Care 1 (33%)
  • Manufacturing 1 (33%)
  • Industrial Automation 1 (33%)
See all 6 industries →

Stage

  • Seed 1 (33%)
  • Series D 1 (33%)
  • Series E 1 (33%)

Country

  • Norway 1 (33%)
  • United States 1 (33%)

Investments

CompanyDescriptionRoundLinks
OTee specializes in the development of industrial automation software, offering a comprehensive solution for the setup, testing, and safe operation of operational facilities in real time. The company's platform is designed to provide automation engineers with a secure, scalable, and user-friendly environment. By utilizing OTee's software,businesses can streamline their operations, allowing them to concentrate on their core tasks while enhancing the performance of their facilities. $1.4M / Seed / Feb 05, 2024
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. They have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize thetraditional glaucoma treatment and management paradigm.They launched the iStent®, their first MIGS device, in the United States in 2012. They are leveraging their platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. They believe the iStent® is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide.In June 2015, they completed an initial public offering and their shares are now traded on the New York Stock Exchange under the ticker symbol “GKOS”. The company was founded in 1998 and is based in San Clemente, California. $29.5M / Series E / Feb 02, 2011
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. They have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize thetraditional glaucoma treatment and management paradigm.They launched the iStent®, their first MIGS device, in the United States in 2012. They are leveraging their platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. They believe the iStent® is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide.In June 2015, they completed an initial public offering and their shares are now traded on the New York Stock Exchange under the ticker symbol “GKOS”. The company was founded in 1998 and is based in San Clemente, California. $35M / Series D / Aug 29, 2008

Co-Investors

Fjord Ventures

About Fjord Ventures

VC Fund · Laguna Hills, United States

Fjord Ventures LLC was founded in mid-2005 and is committed to providing strategic vision and operational excellence to emerging life sciences companies. The Firm is based in Orange County, California.

Fjord Ventures Contacts

NameEmailPhoneSocials
Hugh A.Neuharth
Hugh A.Neuharth Chief Financial Officer
Kristen Apgar Director, Operations & Corporate Administration
Olav Bergheim
Olav Bergheim Founder & MD
Tyler Kibbee Associate

Sign up to unlock verified contacts

Unlock Contacts

See all 4 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Beauty
Medical
Web3
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Fashion
Infrastructure
Social
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Burkina Faso
Africa
LATAM
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Paraguay
South Africa
Botswana
France
Denmark
Georgia
Ghana
Iraq
Sierra Leone
Philippines
El Salvador
Portugal
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Ecuador
Azerbaijan
Bahamas
Bahrain
Jersey
Estonia
Bulgaria
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Lebanon
Liechtenstein
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Olav Bergheim invest in?

Olav Bergheim invests primarily in Medical, Wellness and Health Care startups, most often at Seed and Series D stage. Most of the 3 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Olav Bergheim?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Olav Bergheim last invest?

The most recent investment recorded for Olav Bergheim closed in Feb 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Olav Bergheim Olav Bergheim Find email